3.4099 USD
+0.09 (+2.71%)
Last: Jan 30, 2026, 09:53 AM
GRI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. GRI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GRI does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- In the past year GRI has reported negative net income.
- In the past year GRI has reported a negative cash flow from operations.
- In the past 5 years GRI always reported negative net income.
- In the past 5 years GRI always reported negative operating cash flow.
1.2 Ratios
- GRI has a Return On Assets of -275.12%. This is amonst the worse of the industry: GRI underperforms 90.86% of its industry peers.
- Looking at the Return On Equity, with a value of -660.11%, GRI is doing worse than 77.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -275.12% | ||
| ROE | -660.11% | ||
| ROIC | N/A |
ROA(3y)-261.48%
ROA(5y)-280.2%
ROE(3y)-1860.51%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- GRI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, GRI has more shares outstanding
- GRI has more shares outstanding than it did 5 years ago.
- GRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of -19.31, we must say that GRI is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -19.31, GRI is doing worse than 82.29% of the companies in the same industry.
- There is no outstanding debt for GRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -19.31 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- GRI has a Current Ratio of 1.70. This is a normal value and indicates that GRI is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.70, GRI is doing worse than 78.67% of the companies in the same industry.
- GRI has a Quick Ratio of 1.70. This is a normal value and indicates that GRI is financially healthy and should not expect problems in meeting its short term obligations.
- GRI has a worse Quick ratio (1.70) than 77.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.7 |
3. Growth
3.1 Past
- GRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.24%, which is quite impressive.
EPS 1Y (TTM)98.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 18.81% on average over the next years. This is quite good.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y87.77%
EPS Next 2Y40.13%
EPS Next 3Y25.8%
EPS Next 5Y18.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- GRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GRI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as GRI's earnings are expected to grow with 25.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.13%
EPS Next 3Y25.8%
5. Dividend
5.1 Amount
- GRI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
GRI BIO INC / GRI FAQ
What is the ChartMill fundamental rating of GRI BIO INC (GRI) stock?
ChartMill assigns a fundamental rating of 2 / 10 to GRI.
What is the valuation status of GRI BIO INC (GRI) stock?
ChartMill assigns a valuation rating of 1 / 10 to GRI BIO INC (GRI). This can be considered as Overvalued.
Can you provide the profitability details for GRI BIO INC?
GRI BIO INC (GRI) has a profitability rating of 0 / 10.